Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supportive care in lung cancer.

Michelle Boyar1, Harry Raftopoulos

  • 1Department of Medicine, Columbia University Medical Center, 177 Fort Washington Avenue, MHB6-435, New York, NY 10032, USA.

Hematology/Oncology Clinics of North America
|April 19, 2005
PubMed
Summary

Supportive care is crucial for managing lung cancer symptoms and treatment side effects, significantly improving patient quality of life. Ongoing research aims to further enhance palliative strategies for lung cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.

Journal for immunotherapy of cancer·2019
Same author

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.

Journal for immunotherapy of cancer·2019
Same author

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.

Lung cancer (Amsterdam, Netherlands)·2019
Same author

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2018
Same author

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

Lung cancer (Amsterdam, Netherlands)·2018
Same author

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

The New England journal of medicine·2018

Area of Science:

  • Oncology
  • Palliative Care
  • Patient Quality of Life

Background:

  • Lung cancer significantly impacts patient quality of life due to high morbidity.
  • Supportive care is integral to multimodal lung cancer treatment.
  • Symptom palliation enhances quality of life and treatment adherence.

Purpose of the Study:

  • To review recent advancements in supportive care for lung cancer.
  • To highlight management strategies for disease symptoms and treatment side effects.

Main Methods:

  • Literature review of new developments in supportive care for lung cancer.
  • Focus on symptom management (respiratory issues, pain, cachexia).
  • Focus on treatment side effect management (nausea, neutropenia, anemia, mucositis).

Main Results:

  • Significant advances have been made in supportive care for lung cancer.
  • Improved management of symptoms like respiratory problems, pain, and cachexia.
  • Better control of treatment side effects including chemotherapy-induced nausea and vomiting, neutropenia, anemia, and mucositis.

Conclusions:

  • Supportive care plays a vital role in lung cancer management.
  • Recent developments have improved palliation of lung cancer symptoms and treatment effects.
  • Further research is needed to optimize lung cancer symptom palliation.

Related Experiment Videos